Showing results (21-30 of 42) with videos related to
Sort By:
Pageof 5
Blood|May 15, 1990
Synthetic factor VIII peptides with amino acid sequences contained within the C2 domain of factor VIII inhibit factor VIII binding to phosphatidylserineP A Foster, C A Fulcher, R A Houghten, et al.Thrombosis and Haemostasis|June 28, 1990
A synthetic factor VIII peptide of eight amino acid residues (1677-1684) contains the binding region of an anti-factor VIII antibody which inhibits the binding of factor VIII to von Willebrand factorP A Foster, C A Fulcher, R A Houghten, et al.The Journal of Biological Chemistry|April 15, 1988
An immunogenic region within residues Val1670-Glu1684 of the factor VIII light chain induces antibodies which inhibit binding of factor VIII to von Willebrand factorP A Foster, C A Fulcher, R A Houghten, et al.Journal of in Vitro Fertilization and Embryo Transfer : IVF|August 1, 1989
Effect of bladder filling on embryo transferJ D Mitchell, P G Wardle, P A Foster, et al.Blood|February 1, 1996
The defective interaction between von Willebrand factor and factor VIII in a patient with type 1 von Willebrand disease is caused by substitution of Arg19 and His54 in mature von Willebrand factorP A Kroner, P A Foster, S A Fahs, et al.The Journal of Biological Chemistry|June 25, 1987
A major factor VIII binding domain resides within the amino-terminal 272 amino acid residues of von Willebrand factorP A Foster, C A Fulcher, T Marti, et al.Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|September 1, 1992
The effect of combined estrogen/progestogen treatment in women with hyperprolactinemic amenorrheaU M Fahy, P A Foster, H W Torode, et al.Steroids|February 26, 2021
Development of a LC-MS/MS method to measure serum 3-sulfate and 3-glucuronide 25-hydroxyvitamin D3 metabolites; comparisons to unconjugated 25OHD in pregnancy and polycystic ovary syndromeK Huynh, P Kempegowda, J Tamblyn, et al.The Journal of Clinical Investigation|July 1, 1988
Localization of the binding regions of a murine monoclonal anti-factor VIII antibody and a human anti-factor VIII alloantibody, both of which inhibit factor VIII procoagulant activity, to amino acid residues threonine351-serine365 of the factor VIII heavy chainP A Foster, C A Fulcher, R A Houghten, et al.Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|March 1, 1990
A murine monoclonal anti-factor VIII inhibitory antibody and two human factor VIII inhibitors bind to different areas within a twenty amino acid segment of the acidic region of factor VIII heavy chainP A Foster, C A Fulcher, R A Houghten, et al.Pageof 5